Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/204547 |
Resumo: | The β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine. |
id |
USP-31_b7919ba38c9f7703140c56e371ddd3b3 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/204547 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybridsβ-carboline1,3,5-triazineAcetylcholinesteraseButyrylcholinesteraseThe β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20454710.1590/s2175-97902022e19958Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204547/194769Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessBaréa, PaulaBarbosa, Valéria AquilinoYamazaki, Diego Alberto dos SantosGomes, Carla Maria BeraldiNovello, Claudio R.da Costa, Willian FerreiraGauze, Gisele de FreitasSarragiotto, Maria Helena2023-06-05T12:44:56Zoai:revistas.usp.br:article/204547Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-06-05T12:44:56Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
title |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
spellingShingle |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids Baréa, Paula β-carboline 1,3,5-triazine Acetylcholinesterase Butyrylcholinesterase |
title_short |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
title_full |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
title_fullStr |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
title_full_unstemmed |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
title_sort |
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids |
author |
Baréa, Paula |
author_facet |
Baréa, Paula Barbosa, Valéria Aquilino Yamazaki, Diego Alberto dos Santos Gomes, Carla Maria Beraldi Novello, Claudio R. da Costa, Willian Ferreira Gauze, Gisele de Freitas Sarragiotto, Maria Helena |
author_role |
author |
author2 |
Barbosa, Valéria Aquilino Yamazaki, Diego Alberto dos Santos Gomes, Carla Maria Beraldi Novello, Claudio R. da Costa, Willian Ferreira Gauze, Gisele de Freitas Sarragiotto, Maria Helena |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Baréa, Paula Barbosa, Valéria Aquilino Yamazaki, Diego Alberto dos Santos Gomes, Carla Maria Beraldi Novello, Claudio R. da Costa, Willian Ferreira Gauze, Gisele de Freitas Sarragiotto, Maria Helena |
dc.subject.por.fl_str_mv |
β-carboline 1,3,5-triazine Acetylcholinesterase Butyrylcholinesterase |
topic |
β-carboline 1,3,5-triazine Acetylcholinesterase Butyrylcholinesterase |
description |
The β-carboline-1,3,5-triazine hydrochlorides 8-13 were evaluated in vitro against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The analysed compounds were selective to BuChE, with IC50 values in the range from 1.0-18.8 µM being obtained. The N-{2-[(4,6-dihydrazinyl-1,3,5-triazin-2-yl)amino]ethyl}-1-phenyl-β-carboline-3-carboxamide (12) was the most potent compound and kinetic studies indicate that it acts as a competitive inhibitor of BuChE. Molecular docking studies show that 12 strongly interacts with the residues of His438 (residue of the catalytic triad) and Trp82 (residue of catalytic anionic site), confirming that this compound competes with the same binding site of the butyrylthiocholine. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204547 10.1590/s2175-97902022e19958 |
url |
https://www.revistas.usp.br/bjps/article/view/204547 |
identifier_str_mv |
10.1590/s2175-97902022e19958 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/204547/194769 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222916091052032 |